Thomas Stöhr

Dr. Thomas Stöhr

HyCentA Research GmbH, Graz, Steiermark, Austria
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2024 in International Journal of Hydrogen Energy
Verified
Journal Article
Open access
Thomas StöhrThomas Stöhr
Thomas Stöhr
VRVerena Reiter
Verena Reiter
SSSebastian Scheikl
Sebastian Scheikl
NKNejc Klopcic
Nejc Klopcic
SBStefan Brandstätter
Stefan Brandstätter
ATAlexander Trattner
Alexander Trattner

10 December 2022 in Energies
Verified
Journal Article
Open access
PDF file
NKNejc Klopcic
Nejc Klopcic
Thomas StöhrThomas Stöhr
Thomas Stöhr
IGIlena Grimmer
Ilena Grimmer
MSMarkus Sartory
Markus Sartory
ATAlexander Trattner
Alexander Trattner
Hydrogen is a key enabler of a sustainable society. Refurbishment of the existing natural gas infrastructure for up to 100% H2 is considered one of the most energy- and resource-efficient energy transportation methods. The question remains whether the transportation of 100% H2 with reasonable adaptions of the infrastructure and comparable energy amounts to natural gas is possible. The well-known critical components for refurbishment, such as increased compressor power, reduced linepack as well as pipeline transport efficiencies, and their influencing factors were considered based on thermodynamic calculations with a step-by-step overview. A H2 content of 20–30% results in comparable operation parameters to pure natural gas. In addition to transport in pipelines, decentralized H2 production will also play an important role in addressing future demands.

5 August 2020 in Drugs in R&D
Verified
Journal Article
Open access
PDF file
MPMarija Pesic
Marija Pesic
Thomas StöhrThomas Stöhr
Thomas Stöhr
JOJoachim Ossig
Joachim Ossig
KBKeith Borkett
Keith Borkett
MDMartin Donsbach
Martin Donsbach
FSFrank Schippers
Frank Schippers
Background and Objectives Remimazolam is a new ultra-short-acting benzodiazepine currently being developed for intravenous use in procedural sedation, general anaesthesia, and intensive care unit sedation. Benzodiazepines represent a drug class associated with drug-facilitated sexual assaults, especially in combination with alcohol. Two clinical trials were designed to evaluate the oral bioavailability and pharmacokinetics/pharmacodynamics of remimazolam and to assess the potential for remimazolam misuse in drug-facilitated sexual assaults via oral ingestion. Methods Trial 1 was conducted in 14 healthy volunteers to evaluate the oral bioavailability of remimazolam. Part 1 of trial 2 was conducted in 21 healthy female volunteers to find the minimal biologically active dose of oral remimazolam. Part 2 of trial 2 was conducted in 11 healthy female volunteers to evaluate the pharmacokinetics/pharmacodynamics of oral remimazolam in combination with alcohol. Results Remimazolam undergoes rapid and extensive first-pass metabolism upon oral administration. The oral bioavailability of remimazolam was negligible (2.2% based on total systemic exposure and 1.2% based on maximum plasma concentration). Plasma clearance of both remimazolam and its metabolite was fast (elimination half-life 20‒40 min and 1.75‒2 h, respectively). Alcohol did not appear to inhibit the rapid first-pass metabolism of remimazolam. No clear sedative effects were observed for remimazolam without alcohol. Significant sedation was observed in one of ten subjects after remimazolam 360 mg (18 drug product vials) + 40% v/v alcohol. Conclusion The oral bioavailability of remimazolam is negligible, which—together with its distinct bitter taste—suggests no meaningful potential for misuse in drug-facilitated sexual assaults via oral ingestion, with or without alcohol. Clinical Trial Registration Numbers Trial 1 (NCT04113564) and trial 2 (NCT04113343) both retrospectively registered on 2 October 2019.

16 June 2026 in Hydrogen
Verified
Journal Article
Open access
PDF file
LBLea A. Brandner
Lea A. Brandner
Thomas StöhrThomas Stöhr
Thomas Stöhr
KAKrystel Eugenia Araneda
Krystel Eugenia Araneda
THThomas Hafner
Thomas Hafner
VRVerena Reiter
Verena Reiter
ATAlexander Trattner
Alexander Trattner
Fuel cell electric vehicles (FCEVs) require specific hydrogen purity, as even trace contaminants can degrade proton exchange membrane fuel cells (PEMFCs). While hydrogen quality is monitored along the supply chain according to international standards, potential contamination from in-vehicle materials, such as lubricants and greases, remains largely unexplored. Here, we present a staged testing framework consisting of (i) a rapid pre-screening for formulation stability and (ii) a full qualification pathway to assess lubricant-derived contamination under realistic refueling conditions. Candidate lubricants were exposed to hydrogen in a 700 bar Type IV vessel following an SAE J2601 refueling procedure. Contamination risks were evaluated by optical inspection, particulate matter, and gas analysis, monitoring contaminants specified in ISO 14687:2025 Grade D. The applicability of the framework was demonstrated in practical scenarios. In the pre-screening pathway, a silicone-based formulation fulfilled the 24 h acceptance criteria for formulation stability and was classified as potentially suitable for high-pressure hydrogen tank applications. In contrast, two other lubricants based on silicone and mineral oil exhibited visible changes associated with increased risk of particulate matter release, resulting in a classification of unsuitable. In the full qualification pathway, the fluorinated DuPontTM MOLYKOTE® HP-300 Grease was evaluated over 23 days and showed no release of harmful contaminants into the hydrogen gas, leading to the classification of suitable. Collectively, the presented protocols provide a structured basis for screening and qualifying lubricants for high-pressure hydrogen tanks in PEMFC applications, supporting future standardization in hydrogen technologies.

30 June 2026 in Hydrogen
Verified
Journal Article
Open access
PDF file
NKNejc Klopcic
Nejc Klopcic
KRKarin Rainwald
Karin Rainwald
MKMartin Krennböck
Martin Krennböck
DSDominik Schiffer
Dominik Schiffer
RRRené Regenfelder
René Regenfelder
ATAlexander Trattner
Alexander Trattner
To supply hydrogen to the geographically decoupled demand sites, efficient hydrogen transport is necessary. The existing natural gas pipelines represent a promising transport solution, with the blended hydrogen content expected to steadily increase. An open issue of hydrogen blending is the mixing behavior. Therefore, the effects of different geometric parameters (diameters, angles), operating conditions (velocities, concentrations), and injection layouts (single- and multi-point) on the mixture quality during direct injection of hydrogen into a natural gas pipeline are studied using 3D CFD. The main goal is to find parameters and layouts leading to sufficient mixing quality over a range of operating conditions. The mixing quality is determined based on the coefficient of variation (COV). The results show that the momentum flux ratio is a key parameter governing the mixing behavior. However, a high momentum flux ratio alone does not guarantee sufficient uniformity for all operating conditions. For the investigated range, single-point injection cannot ensure reliable mixing quality, whereas multi-point layouts with higher hydrogen inlet velocities achieve sufficient uniformity.

1 January 2016
Verified
Book Chapter
Closed access
BSBenedikte Serruys
Benedikte Serruys
Thomas StöhrThomas Stöhr
Thomas Stöhr
HUHans Ulrichts
Hans Ulrichts
KVKatrien Vanheusden
Katrien Vanheusden
MRMaarten Van Roy
Maarten Van Roy